{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:29:32Z","timestamp":1770514172469,"version":"3.49.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.2169\/internalmedicine.1407-22","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T22:11:15Z","timestamp":1689718275000},"page":"671-676","source":"Crossref","is-referenced-by-count":1,"title":["Immunosuppressive Treatment for an anti-U<sub>1<\/sub> Ribonucleoprotein Antibody-positive Patient with Pulmonary Arterial Hypertension"],"prefix":"10.2169","volume":"63","author":[{"given":"Kazuya","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takato","family":"Nakadoi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Shidahara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Nawachi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Takano-Narazaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Akagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"},{"name":"Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62: D34-D41, 2013.","DOI":"10.1016\/j.jacc.2013.10.029"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Burger CD, DuBrock HM, Cartin-Ceba R, Moss JE, Shapiro BP, Frantz RP. Topic-based, recent literature review on pulmonary hypertension. Mayo Clin Proc 96: 3109-3121, 2021.","DOI":"10.1016\/j.mayocp.2021.05.026"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gali\u00e8 N, Humbert M, Vachiery JL, et al.; The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 37: 67-119, 2016.","DOI":"10.1093\/eurheartj\/ehv317"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ogawa A, Nakamura K, Mizoguchi H, et al. Prednisolone ameliorates idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 183: 139-140, 2011.","DOI":"10.1164\/ajrccm.183.1.139"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest 130: 182-189, 2006.","DOI":"10.1378\/chest.130.1.182"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yasuoka H, Shirai Y, Tamura Y, Takeuchi T, Kuwana M. Predictors of favorable responses to immunosuppressive treatment in pulmonary arterial hypertension associated with connective tissue disease. Circ J 82: 546-554, 2018.","DOI":"10.1253\/circj.CJ-17-0351"},{"key":"7","unstructured":"7. Tojo T. guide to the diagnosis of mixed connective tissue diseases (revised 1996). In: Ministry of the Health and Welfare, Mixed Connective Tissue Disease Research Committee, 1995 Report. Ministry of Health and Walfare, 1996: 3 (in Japanese)."},{"key":"8","unstructured":"8. Mimori T. Guidelines for the treatment of mixed connective tissue diseases.  (3rd edition). Grant-in-Aid for Scientific Research, Research on Measures for Intractable Diseases, Ministry of the Health and Welfare, Mixed Connective Tissue Disease Research Committee, 2011 (in Japanese)."},{"key":"9","unstructured":"9. Jones RJ, De Bie E, Groves E, et al. Autoimmunity is a significant feature of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 206: 81-93, 2022."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Vegh J, Soos G, Csipo I, et al. Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost. Rheumatol Int 26: 264-269, 2006.","DOI":"10.1007\/s00296-005-0616-8"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Chow SL, Chandran V, Fazelzad R, Johnson SR. Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension. Lupus 21: 353-364, 2012.","DOI":"10.1177\/0961203311429815"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sobanski V, Giovannelli J, Lynch BM, et al. Characteristics and survival of anti-U1 RNP antibody-positive patients with connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheumatol 68: 484-493, 2016.","DOI":"10.1002\/art.39432"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Thakkar V, Lau EM. Connective tissue disease-related pulmonary arterial hypertension. Best Pract Res Clin Rheumatol 30: 22-38, 2016.","DOI":"10.1016\/j.berh.2016.03.004"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg-Maitland M. Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. J Heart Lung Transplant 29: 181-187, 2010.","DOI":"10.1016\/j.healun.2009.07.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ramjug S, Hussain N, Hurdman J, et al. Idiopathic and systemic sclerosis-associated pulmonary arterial hypertension: a comparison of demographic, hemodynamic, and MRI characteristics and outcomes. Chest 152: 92-102, 2017.","DOI":"10.1016\/j.chest.2017.02.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Miyamichi-Yamamoto S, Fukumoto Y, Sugimura K, et al. Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease. Circ J 75: 2668-2674, 2011.","DOI":"10.1253\/circj.CJ-11-0473"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_1407-22\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:31:10Z","timestamp":1715574670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_1407-22\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1407-22","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"article-number":"1407-22"}}